Article Details

Sanofi/GSK/Haleon: cancer fears prove hard to stomach | The Week UK

Retrieved on: 2022-08-19 20:54:34

Tags for this article:

Click the tags to see associated articles and topics

Sanofi/GSK/Haleon: cancer fears prove hard to stomach | The Week UK. View article details on hiswai:

Excerpt

Damages, if awarded, could be as high as $45bn, according to Morgan Stanley. And since rights of the over-the-counter version of Zantac have been ...

Article found on: www.theweek.co.uk

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up